CIK 0001650648
- Non-accelerated filer
- Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473506994
- Phone
- +1 510-505-2680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,616,428
- in 5 filings, $1.6M under 10b5-1 plans
Net −$1,616,428. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-17 | Chacko Jacob Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-06-17 | Chacko Jacob Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2024-05-21 | Chacko Jacob Director | Grant or award · Stock Option (Right To Buy) | +22,500 | 22,500 | ||
| 2023-05-23 | Chacko Jacob Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2023-04-21 | Chacko Jacob Director | Exercise or conversion 10b5-1 | +5,000 | $9.41 | $47K | 5,000 |
| 2023-04-21 | Chacko Jacob Director | Sale 10b5-1 | −5,000 | $20.05 | $100K | 0 |
| 2023-04-21 | Chacko Jacob Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −5,000 | 32,500 | ||
| 2022-05-23 | Chacko Jacob Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2021-05-17 | Chacko Jacob Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 |
Page 1 of 1 · 9 trades